Nissan Chemical Corp

Chart & Performance

D1W1MN

P/E

17.67

P/S

2.96

EPS

276.49

Div Yield, %

3.42%

Shrs. gr., 5y

-1.27%

Rev. gr., 5y

2.04%

Revenues

226.71b

-0.60%

Net income

38.03b

-7.43%

CFO

33.70b

-4.33%

Dividend

Mar 28, 20250 JPY/sh

Earnings

Feb 07, 2025

Profile

Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; OPTBEADS, a melamine-formaldehyde resin and silica; and FINEOXOCOL, a saturated fatty alcohol and acid. The company also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, it provides pharmaceutical products, such as LIVALO, a cholesterol reduction agent; LANDEL and FINTE, a dual type calcium antagonist that blocks calcium channels; and custom manufacturing and process researching services for pharmaceutical ingredients. Further, the company develops healthcare, information and communication materials, and environmental and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.

URL

https://www.nissanchem.co.jp/

IPO date

May 16, 1949

Employees

2,965

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03	2015‑03
Income
Revenues	226,705,000 -0.60%	228,065,000 9.66%	207,972,000 -0.55%
Cost of revenue	186,372,000	183,398,000	164,132,000
Unusual Expense (Income)
NOPBT	40,333,000	44,667,000	43,840,000
NOPBT Margin	17.79%	19.59%	21.08%
Operating Taxes	13,578,000	15,187,000	15,026,000
Tax Rate	33.66%	34.00%	34.27%
NOPAT	26,755,000	29,480,000	28,814,000
Net income	38,033,000 -7.43%	41,087,000 5.96%	38,776,000 15.85%
Dividends	(22,973,000)	(20,084,000)	(15,468,000)
Dividend yield	2.88%	2.38%	1.50%
Proceeds from repurchase of equity	(10,006,000)	(4,387,000)	(11,846,000)
BB yield	1.25%	0.52%	1.15%
Debt
Debt current	39,696,000	25,951,000	21,533,000
Long-term debt	1,284,000	1,338,000	1,182,000
Deferred revenue		1,259,000	1,814,000
Other long-term liabilities	3,278,000	2,334,000	2,644,000
Net debt	(8,753,000)	(34,898,000)	(47,152,000)
Cash flow
Cash from operating activities	33,701,000	35,226,000	41,949,000
CAPEX	(21,223,000)	(20,173,000)	(12,852,000)
Cash from investing activities	(18,741,000)	(19,643,000)	(12,395,000)
Cash from financing activities	(22,101,000)	(25,030,000)	(27,868,000)
FCF	(9,670,000)	590,000	20,244,000
Balance
Cash	22,738,000	29,647,000	34,658,000
Long term investments	26,995,000	32,540,000	35,209,000
Excess cash	38,397,750	50,783,750	59,468,400
Stockholders' equity	218,231,000	422,867,000	399,342,000
Invested Capital	236,762,250	193,744,250	167,001,600
ROIC	12.43%	16.34%	17.89%
ROCE	14.58%	18.26%	19.35%
EV
Common stock shares outstanding	139,408	141,020	142,624
Price	5,725.00 -4.42%	5,990.00 -17.15%	7,230.00 22.34%
Market cap	798,110,399 -5.52%	844,708,704 -18.08%	1,031,173,826 20.80%
EV	792,789,399	1,021,763,704	1,182,805,826
EBITDA	54,134,000	55,646,000	54,062,000
EV/EBITDA	14.64	18.36	21.88
Interest	526,000	252,000	73,000
Interest/NOPBT	1.30%	0.56%	0.17%